HIF-1 News

Latest Articles

• Novel Dual-Inhibitor Drugs Achieve Complete Tumor Remission in Preclinical Immunotherapy Trials

  Published: Apr 3, 2026

  Section: Medical News

  Researchers from Johns Hopkins University and the University of Maryland have developed a first-in-class class of oral drugs that target both HIF-1 and HIF-2, the "master regulator...